{
    "Trade/Device Name(s)": [
        "cobas SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas Liat System",
        "cobas SARS-CoV-2 & Influenza A/B for use on the cobas Liat System",
        "cobas SARS-CoV-2 & Influenza A/B"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K223591",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN200031"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF"
    ],
    "Summary Letter Date": "January 29, 2024",
    "Summary Letter Received Date": "",
    "Submission Date": "November 30, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-Cov-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "SARS-CoV-2 (ORF1 a/b, nucleocapsid protein)",
        "Influenza A (matrix gene)",
        "Influenza B (nonstructural protein gene)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal swab",
        "Anterior nasal swab"
    ],
    "Specimen Container(s)": [
        "Copan FLOQSwabs with UTM",
        "UVT",
        "Other swabs with other viral transport media (VTM) such as M4RT, M4, M5, M6",
        "0.9% Saline"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas Liat System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR",
        "Multiplex assay",
        "Automated rapid nucleic acid amplification"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex PCR",
        "Automated sample preparation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Nucleic acid test",
        "Multiplex",
        "Automated system",
        "Platform"
    ],
    "Document Summary": "FDA 510(k) summary for cobas SARS-CoV-2 & Influenza A/B multiplex RT-PCR test for qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B on cobas Liat System",
    "Indications for Use Summary": "Qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B viral nucleic acid in nasopharyngeal and anterior nasal swab specimens from individuals with signs and symptoms of respiratory tract infection as an aid in differential diagnosis, for use with the cobas Liat System",
    "fda_folder": "Microbiology"
}